sharon sanders
Editor-in-Chief & President
Apparently became ill in early May.....
A man suffered from cough and fever for several days, and a check-up revealed that he had a rare type of pneumonia, occurring in only one in a million people…
June 25, 2026, 16:15, Jiading District, Shanghai
Mr. Cai, an avid fisherman, never imagined that a seemingly ordinary cough and fever would push him to the brink of developing "white lung," a critical condition. Even more surprising to him and his family was that the culprit was a rare bacterium with an annual incidence rate of only one in a million…
Not long ago, Mr. Cai, a patient , went to Renji Hospital Jiading Branch (Jiading District Central Hospital) for treatment due to cough and phlegm for 8 days, fever and shortness of breath for 3 days, and diarrhea. At the time of his visit, Mr. Cai had multiple symptoms consistent with severe pneumonia and was admitted to the Emergency Intensive Care Unit ( EICU ) on the same day . He was eventually diagnosed with severe pneumonia, acute respiratory failure, acute respiratory distress syndrome, and hypertension.
To determine the cause of the illness as early as possible, the EICU medical team performed a fiberoptic bronchoscopy on Mr. Cai on the day of admission and collected bronchoalveolar lavage fluid samples, while simultaneously initiating precise pathogen testing. The test results were quickly reported the following day, detecting Tropheryma whipplei. Based on the patient's clinical symptoms, signs, and laboratory indicators, it was determined that this bacterium was highly likely to be the pathogen.
Whipple's disease is a Gram-positive bacillus belonging to the phylum Actinobacteria. This bacterium is widely found in the environment, such as in soil and sewage. The classic Whipple's disease it causes primarily presents with gastrointestinal symptoms and joint involvement, and is more common in middle-aged men. The estimated annual incidence is approximately 1 in 1,000,000 to 1 in 100,000, classifying it as a rare disease. Reports of severe pneumonia caused by Whipple's disease are even rarer, both domestically and internationally.
The diagnosis was largely clear, but challenges arose: how to develop an anti-infection regimen that was both precise and safe? Based on standard treatment, and considering the drug sensitivity characteristics and evidence-based data of Whipple's disease, as well as the patient's current critical condition, the EICU team decisively adjusted the treatment plan: meropenem combined with sulfamethoxazole-trimethoprim, which is the core drug recommended by domestic and international guidelines for the treatment of Whipple's disease.
After 40 days of treatment, Mr. Cai's body temperature gradually returned to normal, his shortness of breath significantly improved, and his inflammation and infection markers continued to decline. Subsequent chest CT scans showed that the infection lesions in both lungs had significantly resolved, and he was eventually discharged from the hospital.
Shortly after being discharged, Mr. Cai and his family made a special trip back to the hospital to present a banner to the department team—"Exquisite medical skills to cure white lung, gentle care like family"—conveying the patient's deep trust and gratitude to the medical team.
From respiratory distress and hanging by a thread to a smiling face and personally presenting a banner of appreciation, this harrowing 40-day journey is not only a testament to a miracle of life, but also a hard-core contest of precision medicine and critical care capabilities. In recent years, the Department of Emergency and Critical Care Medicine at Renji Hospital Jiading Branch (Jiading District Central Hospital) has continuously deepened its capacity for critical care, keeping abreast of the forefront of the field. It has maturely implemented techniques such as cardiopulmonary resuscitation (including ECPR), extracorporeal membrane oxygenation (ECMO), temporary cardiac pacing, intra-aortic balloon pump (IABP), and minimally invasive percutaneous tracheotomy (including bronchoscopic/ultrasound-guided procedures). It has continuously achieved technological breakthroughs in the field of critical care, forming a comprehensive treatment system covering the entire chain of "precision diagnosis—life support—organ replacement—minimally invasive intervention," effectively building the last line of defense for patients' lives.
zhttps://finance.sina.com.cn/wm/2026-06-25/doc-inierihu5671492.shtml
A man suffered from cough and fever for several days, and a check-up revealed that he had a rare type of pneumonia, occurring in only one in a million people…
June 25, 2026, 16:15, Jiading District, Shanghai
Mr. Cai, an avid fisherman, never imagined that a seemingly ordinary cough and fever would push him to the brink of developing "white lung," a critical condition. Even more surprising to him and his family was that the culprit was a rare bacterium with an annual incidence rate of only one in a million…
Not long ago, Mr. Cai, a patient , went to Renji Hospital Jiading Branch (Jiading District Central Hospital) for treatment due to cough and phlegm for 8 days, fever and shortness of breath for 3 days, and diarrhea. At the time of his visit, Mr. Cai had multiple symptoms consistent with severe pneumonia and was admitted to the Emergency Intensive Care Unit ( EICU ) on the same day . He was eventually diagnosed with severe pneumonia, acute respiratory failure, acute respiratory distress syndrome, and hypertension.
To determine the cause of the illness as early as possible, the EICU medical team performed a fiberoptic bronchoscopy on Mr. Cai on the day of admission and collected bronchoalveolar lavage fluid samples, while simultaneously initiating precise pathogen testing. The test results were quickly reported the following day, detecting Tropheryma whipplei. Based on the patient's clinical symptoms, signs, and laboratory indicators, it was determined that this bacterium was highly likely to be the pathogen.
Whipple's disease is a Gram-positive bacillus belonging to the phylum Actinobacteria. This bacterium is widely found in the environment, such as in soil and sewage. The classic Whipple's disease it causes primarily presents with gastrointestinal symptoms and joint involvement, and is more common in middle-aged men. The estimated annual incidence is approximately 1 in 1,000,000 to 1 in 100,000, classifying it as a rare disease. Reports of severe pneumonia caused by Whipple's disease are even rarer, both domestically and internationally.
The diagnosis was largely clear, but challenges arose: how to develop an anti-infection regimen that was both precise and safe? Based on standard treatment, and considering the drug sensitivity characteristics and evidence-based data of Whipple's disease, as well as the patient's current critical condition, the EICU team decisively adjusted the treatment plan: meropenem combined with sulfamethoxazole-trimethoprim, which is the core drug recommended by domestic and international guidelines for the treatment of Whipple's disease.
After 40 days of treatment, Mr. Cai's body temperature gradually returned to normal, his shortness of breath significantly improved, and his inflammation and infection markers continued to decline. Subsequent chest CT scans showed that the infection lesions in both lungs had significantly resolved, and he was eventually discharged from the hospital.
Shortly after being discharged, Mr. Cai and his family made a special trip back to the hospital to present a banner to the department team—"Exquisite medical skills to cure white lung, gentle care like family"—conveying the patient's deep trust and gratitude to the medical team.
From respiratory distress and hanging by a thread to a smiling face and personally presenting a banner of appreciation, this harrowing 40-day journey is not only a testament to a miracle of life, but also a hard-core contest of precision medicine and critical care capabilities. In recent years, the Department of Emergency and Critical Care Medicine at Renji Hospital Jiading Branch (Jiading District Central Hospital) has continuously deepened its capacity for critical care, keeping abreast of the forefront of the field. It has maturely implemented techniques such as cardiopulmonary resuscitation (including ECPR), extracorporeal membrane oxygenation (ECMO), temporary cardiac pacing, intra-aortic balloon pump (IABP), and minimally invasive percutaneous tracheotomy (including bronchoscopic/ultrasound-guided procedures). It has continuously achieved technological breakthroughs in the field of critical care, forming a comprehensive treatment system covering the entire chain of "precision diagnosis—life support—organ replacement—minimally invasive intervention," effectively building the last line of defense for patients' lives.
zhttps://finance.sina.com.cn/wm/2026-06-25/doc-inierihu5671492.shtml